This site is intended for health professionals only
During Pulse PCN Events, you will also have the opportunity to find out more about the latest innovations from our handpick selection of suppliers. By clicking on the logo you will be able to access their websites and learn more about the latest products and services.
If you are interested in participating, please contact us.Interested in exhibiting?
Anima is the next generation online consultation platform for PCNs and GP practice teams. Anima provides PCNs and practice teams with everything you need to manage any patient request end-to-end in a single platform. Unprecedented levels of control, customisation and automation and productivity tools help supercharge your entire team and co-ordinate great care across your organisation. Built by doctors, approved by NHS Digital, and integrated with EMIS & SystmOne, Anima really is the “most advanced GP consultation platform around” (eGPlearning).
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Galderma is a leader in research and development of scientifically defined and medically proven dermatology solutions seeking to enhance the quality of patient’s lives. Galderma’s Prescription Medicine business is focused on prescription treatments that offer patients relief from the burden of mild, moderate and severe skin diseases and is supported by a wide-ranging portfolio with innovation focused on the development of new therapies in disease areas with current unmet medical needs.
No more long paper lists of patients for QOF review.
Codepilot reduces GP workload by identifying patients that are missing from disease registers.
Distribute these records electronically to the most appropriate staff member for review. Codepilot halves the time it normally takes to do each of these reviews.
Correctly coding patients results in improved quality of care for patients and increased income for the practice.
See how Codepilot can help your practice by visiting our stand or www.codepilot.app
Prescribing Care Direct (PCD) has recognised an increasing need for the deployment of practice pharmacist services. We provide a range of primary care medicines optimisation services, including care home and discharge support.
At PCD, we have highlighted that general practitioners spend approximately 20 – 30% of their time dealing with an extensive range of activities relating to prescribing.
The aims of the services provided by PCD are to reduce the workload of the GP through our highly skilled and experienced workforce.
As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 110,000 people of more than 140 nationalities work at Novartis around the world. In the UK, we employ approximately 1,300 people to serve healthcare needs across the whole of the UK, as well as supporting the global operations of Novartis. Since 2014, Novartis has invested over £200 million in R&D and is the single largest industry sponsor of clinical trials in the UK. For more information, please visit www.novartis.co.uk
Chiesi Limited is headquartered in Manchester and employs over 400 people. Based in Parma, Italy, Chiesi Farmaceutici is an international research-oriented group with over 80 years’ experience in the pharmaceutical sector, operating in 29 countries and employing around 5,700 people.
Chiesi researches, develops and markets innovative drugs for respiratory treatment, special care medicine, and rare diseases, with its Research and Development Centre also based in Parma. Chiesi is a certified Benefit Corporation (B Corp®) and is committed to operating in an environmentally responsible manner.
L&R has more than 160 years of experience developing outstanding wound care and compression therapy solutions
As a trusted, innovative and responsive partner, we are well positioned to support the NHS in overcoming the challenges they face in the provision of wound care and improving patient outcomes and experience.
We collaborate extensively with leading clinicians to:
– provide evidence-based solutions that deliver clinical transformation and service efficiencies, backed by education and coaching
– ensure that we can offer you the support you need to raise standards of wound care enabling you to improve patient outcomes and meet targets.
For more information visit L&R’s website:
Pulse Intelligence allows you to match your practice to others around the country and highlight ways in which you can maximise your own practice profits. Using official NHS data, we have collected information on your income, staff, and practice demographics to provide a whole picture on your practice’s finances, and offers guidance articles on how you can improve your funding.
Increase the efficiency of staff by replacing unnecessary appointments with automatic monitoring of blood pressure, height and weight.
HCM range of medically approved, automatic monitors have audio and visual instructions enabling unsupervised monitoring of height, weight, BMI, blood pressure and pulse. The compact units fit neatly into the waiting area so that routine measurements are made before consultation. Tickets are printed for reference, the results can also be integrated directly to the patient records (EMIS, SystmOne and Microtest.) Why not sign-up for a free, no obligation, month long trial in surgery?
Tel: 01299 250321
email: [email protected]